Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
145.95
+0.41 (+0.28%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
96
97
Next >
Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy
May 07, 2024
Johnson & Johnson unveils promising TARIS platform data for bladder cancer treatment, highlighting ease of administration and significant revenue potential.
Via
Benzinga
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.
Via
InvestorPlace
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
May 06, 2024
Johnson & Johnson's results in treating bladder and prostate cancer. Learn about TAR-210's efficacy in high-risk NMIBC patients and TAR-200's promising outcomes for BCG-unresponsive cases.
Via
Benzinga
Steady Dividend Plays: 3 Aristocrat Stocks to Own Now
May 06, 2024
Seeking steady income? These dividend aristocrat stocks offer dependable yields and a history of dividend growth.
Via
InvestorPlace
Comparing Johnson & Johnson With Industry Competitors In Pharmaceuticals Industry
May 06, 2024
Via
Benzinga
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
April 30, 2024
Via
Benzinga
Johnson & Johnson Stock: Buy, Sell, or Hold?
April 27, 2024
Is this top healthcare stock worth adding to your portfolio today?
Via
The Motley Fool
Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?
May 06, 2024
Investors often wonder what to make of spinoff stocks with these three recent moves to watch providing varying outcomes and future potential.
Via
InvestorPlace
Johnson & Johnson: A Healthcare Giant That's Looking More Attractive By The Day
May 04, 2024
Johnson & Johnson is the largest healthcare products firm in the world by sales, spanning pharmaceuticals, medical devices, and consumer products. Plus, its shares only look more attractive as time...
Via
Talk Markets
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
May 03, 2024
As new robotic surgery systems loom, Intuitive Surgical investors await a "game-changer."
Via
Investor's Business Daily
3 Dividend Growth Stocks that Just Raised Their Payouts
May 03, 2024
One of these stocks boosted its payouts by as much as 13%.
Via
The Motley Fool
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
May 01, 2024
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results.
Via
InvestorPlace
Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package
May 01, 2024
Johnson & Johnson announces $6.475 billion settlement for talc-related ovarian cancer lawsuits. Details on proposed resolution.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
May 02, 2024
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jones Industrial Average Struggles To Recover From Recent Backslide As Fed Rounds Corner
May 01, 2024
After this week's backslide, the Dow Jones Industrial Average (DJIA) is stuck in a rut, dragging the index below 38,000.00 as investors buckle down for another rate call from the US Federal Reserve...
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally
May 01, 2024
Cannabis stocks are falling on Wednesday as shares of marijuana companies are giving up some of the massive gains they saw yesterday.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Why Is CytomX (CTMX) Stock Up 180% Today?
May 01, 2024
CytomX stock is rising higher on Wednesday as CTMX investors get an update on its upcoming earnings and clinical trial news.
Via
InvestorPlace
JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits
May 01, 2024
Johnson & Johnson stock is up on Wednesday as JNJ investors learn of plans for a $6.5 billion settlement to its talc lawsuits.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $200 Right Now
May 01, 2024
You don't need a mountain of cash to grow your wealth on Wall Street.
Via
The Motley Fool
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks
April 30, 2024
These are the list of healthcare stocks to avoid that present challenges indicating signs of a crash in the near future.
Via
InvestorPlace
Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn
April 30, 2024
Discover how these stocks may progress in consumer staples, health care, and tech sectors and outperform the S&P 500.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Cutting Edge Picks: 3 Med Tech Stocks With Room to Run
April 29, 2024
The med tech stocks are worth checking out for value investors seeking potentially overlooked growth catalysts.
Via
InvestorPlace
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
April 29, 2024
Latest Phase 2 epilepsy study findings on ADX71149 adjunctive therapy for focal onset seizures. Partnered with Janssen, Addex Therapeutics evaluates treatment efficacy in patients with suboptimal...
Via
Benzinga
Johnson & Johnson Is a King of Dividend Safety
April 29, 2024
The healthcare behemoth has fortified its dividend.
Via
The Motley Fool
7 Retirement Stocks to Buy at a 52-Week Low in April
April 29, 2024
One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
April 28, 2024
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for...
Via
Talk Markets
2 Top Growth Stocks to Buy Right Now and Hold Forever
April 28, 2024
These healthcare stocks can provide enviable long-term portfolio growth.
Via
The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
April 28, 2024
One thing is for sure: Dividend seekers can't go wrong with either.
Via
The Motley Fool
5 Stocks In Focus On Their Recent Dividend Hikes
April 27, 2024
Wall Street’s impressive bull run for the last 15 months has been facing severe hurdles in April. In such an environment, it may be prudent to consider stocks that consistently deliver dividends. Here...
Via
Talk Markets
7 Stocks to Buy if Inflation Continues to Reign in 2024
April 27, 2024
The latest inflation readings showed consumers won't get low prices anytime soon, here are seven stocks to buy if inflation continues to rise
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
7
8
9
...
96
97
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.